Drug profile · INN
losartan potassium
LOSARTAN POTASSIUM
losartan potassium (LOSARTAN POTASSIUM) is a type-1 angiotensin ii receptor antagonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Drug details — losartan potassium
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 1
- Programs
- 5
- Data quality
- 0.89
Quick answer
losartan potassium (LOSARTAN POTASSIUM) is a type-1 angiotensin ii receptor antagonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Type-1 angiotensin II receptor antagonist
Primary target: Type-1 angiotensin II receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is losartan potassium?
losartan potassium (LOSARTAN POTASSIUM) is a type-1 angiotensin ii receptor antagonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for losartan potassium?
LOSARTAN POTASSIUM is a marketed brand name for losartan potassium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of losartan potassium?
losartan potassium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.